Characterisation of phenotYpes in aCute Heart faiLure patiEnts
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitätsklinikum Hamburg-Eppendorf
About this trial
An observational cohort study to evaluate the benefit of functional parameters, radiomics and blood biomarkers to predict the outcome of patients with acute heart failure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Clinical diagnosis of acute heart failure, including all stages of cardiogenic shock, de novo heart failure as well as decompensated chronic heart failure.
Hospitalisation due to acute heart failure or new-onset acute heart failure during a hospitalisation de to a different cause. Out-patients with acute heart failure are not included.
Disqualifiers
Age < 18 years
No written informed consent.
Trial population
Hospitalised patients with acute heart failure of any aetiology and stage at a German tertiary care centre.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Time to cardiovascular death or first rehospitalisation for heart failure
Etiologies of death and hospitalisation will be adjudicated by local investigators. Time-to-event analyses are planned for the primary outcome.
Time frame
from enrolment up to 5 yearsSecondary outcomes
1
Incidence rate of cardiovascular death and total rehospitalisations for heart failure
Etiologies will be adjudicated by local investigators. Repeated event analyses are planned for this secondary outcome.
Time frame
from enrolment up to 5 years2
Time to cardiovascular death
Cause of death adjudicated by local investigators. Time-to-event analysis.
Time frame
from enrolment up to 5 years3
Time to first rehospitalisation for heart failure
Etiologies will be adjudicated by local investigators. Time-to-event analyses are planned.
Time frame
from enrolment up to 5 years4
Incidence rate of total rehospitalisations for heart failure
Etiologies will be adjudicated by local investigators. Repeated event analyses are planned.
Time frame
from enrolment up to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov